Davenport D S, Massanari R M, Pfaller M A, Bale M J, Streed S A, Hierholzer W J
J Infect Dis. 1986 Feb;153(2):332-9. doi: 10.1093/infdis/153.2.332.
The usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci and its implications for therapy were examined. Hospital records were reviewed for 59 patients from each of whom more than one isolate of coagulase-negative staphylococci was obtained. In patients with a prosthetic device, 81% of 59 infectious episodes were due to a slime-positive coagulase-negative staphylococci. In contrast, 22 noninfectious episodes (in which the organisms were contaminants) were equally distributed between episodes due to slime-positive or slime-negative isolates (P = .005). Only 32% of infections caused by slime-positive organisms, in contrast to 100% of infections caused by slime-negative organisms, were improved by treatment with antibiotics alone (P = .02). Prosthetic device removal in addition to antibiotic treatment significantly improved the outcome in patients with infections due to slime-positive organisms when compared with treatment with antibiotics alone (93% vs. 32% improvement; P = .00025).
对检测黏液产生作为凝固酶阴性葡萄球菌临床显著感染标志物的实用性及其对治疗的影响进行了研究。回顾了医院记录,其中59例患者每人获得了不止一株凝固酶阴性葡萄球菌。在有假体装置的患者中,59次感染发作中有81%是由黏液阳性凝固酶阴性葡萄球菌引起的。相比之下,22次非感染发作(其中微生物为污染物)在由黏液阳性或黏液阴性分离株引起的发作中分布均匀(P = 0.005)。与黏液阴性微生物引起的感染100%相比,仅32%由黏液阳性微生物引起的感染通过单独使用抗生素治疗得到改善(P = 0.02)。与单独使用抗生素治疗相比,除抗生素治疗外取出假体装置显著改善了黏液阳性微生物引起感染的患者的治疗结果(改善率分别为93%和32%;P = 0.00025)。